CXHL2200828 | AK0706片 | AK-0706 | Tablet | Chemical Drugs(1) | New Drug Application | 2022-10-25 | | Xiamen Amoytop Biotech Co Ltd | | | view |
CXHL2200829 | AK0706片 | AK-0706 | Tablet | Chemical Drugs(1) | New Drug Application | 2022-10-25 | | Xiamen Amoytop Biotech Co Ltd | | | view |
CXSB1100008 | Y型PEG化重组人干扰素α2b注射液 | peginterferon alfa-2b | Injection | Biological Products | Supplementary Application | 2011-06-08 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2012-03-13 | view |
CXSB1100015 | Y型PEG化重组人干扰素α2b注射液 | peginterferon alfa-2b | Injection | Biological Products | Supplementary Application | 2011-10-08 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2012-10-30 | view |
CXSB1100016 | Y型PEG化重组人干扰素α2a注射液 | Peginterferon alfa-2a | Injection | Biological Products | Supplementary Application | 2011-11-17 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2012-12-25 | view |
CXSB1200013 | Y型PEG化重组人粒细胞刺激因子注射液 | | Injection | Biological Products | Supplementary Application | 2012-08-01 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2013-09-13 | view |
CXSB1300010 | 注射用重组人生长激素 | Somatropin | Lyophilized | Biological Products | Supplementary Application | 2013-05-02 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2014-10-31 | view |
CXSB1900005 | Y型PEG化重组人粒细胞刺激因子注射液 | | Injection | Biological Products | Supplementary Application | 2019-03-13 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | In Review | 2019-03-12 | view |
CXSB1900011 | Y型PEG化重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2019-06-05 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | In Review | 2019-06-04 | view |
CXSL0500012 | 注射用重组人生长激素 | Somatropin | Lyophilized | Biological Products(10) | New Drug Application | 2005-02-22 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | In Approval | 2007-03-19 | view |
CXSL0500013 | 重组人白细胞介素-2注射液 | Recombinant Human Interleukin-2 | Injection | Biological Products(10) | New Drug Application | 2005-02-22 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Completed-Pending Issued | 2007-05-08 | view |
CXSL0500060 | 重组人干扰素α2a注射液 | recombinant human interferon α2a | Injection | Biological Products(10) | New Drug Application | 2005-07-18 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2007-06-12 | view |
CXSL0500063 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(10) | New Drug Application | 2005-07-10 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2006-12-30 | view |
CXSL0700020 | Y型PEG化重组人干扰素α2b注射液 | peginterferon alfa-2b | Injection | Biological Products(1) | New Drug Application | 2007-09-10 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2009-04-29 | view |
CXSL0700028 | Y型PEG化重组人干扰素α2a注射液 | Peginterferon alfa-2a | Injection | Biological Products(1) | New Drug Application | 2007-10-25 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2010-11-23 | view |
CXSL0700039 | Y型PEG化重组人粒细胞刺激因子注射液 | | Injection | Biological Products(1) | New Drug Application | 2008-02-26 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2010-03-11 | view |
CXSL0800002 | Y型PEG化重组人生长激素注射液 | | Injection | Biological Products(1) | New Drug Application | 2008-02-26 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2010-05-13 | view |
CXSL0900006 | Y型PEG化重组人促红素注射液 | | Injection | Biological Products(1) | New Drug Application | 2009-05-15 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2011-12-13 | view |
CXSL1100077 | 重组人白介素-11注射液 | recombinant human interleukin-11 | Injection | Biological Products(13) | New Drug Application | 2012-01-11 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | Certificate Issued | 2013-01-30 | view |
CXSL1900018 | 聚乙二醇干扰素α-2b注射液 | peginterferon alfa-2b | Injection | Biological Products(1) | New Drug Application | 2019-03-05 | 厦门特宝生物工程股份有限公司 | Xiamen Amoytop Biotech Co Ltd | In Review | 2019-03-04 | view |